Alcon Property, Plant, and Equipment 2019-2024 | ALC
Alcon property, plant, and equipment from 2019 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
- Alcon property, plant, and equipment for the quarter ending June 30, 2024 was $4.330B, a 5.89% increase year-over-year.
- Alcon property, plant, and equipment for 2023 was $4.369B, a 8.55% increase from 2022.
- Alcon property, plant, and equipment for 2022 was $4.025B, a 8.46% increase from 2021.
- Alcon property, plant, and equipment for 2021 was $3.711B, a 8.35% increase from 2020.
| Alcon Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2023 | $4,369 |
| 2022 | $4,025 |
| 2021 | $3,711 |
| 2020 | $3,425 |
| 2019 | $3,113 |
| 2018 | $2,800 |
| Alcon Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024-06-30 | $4,330 |
| 2024-03-31 | $4,329 |
| 2023-12-31 | $4,369 |
| 2023-09-30 | $4,125 |
| 2023-06-30 | $4,089 |
| 2023-03-31 | $4,063 |
| 2022-12-31 | $4,025 |
| 2022-09-30 | $3,740 |
| 2022-06-30 | $3,742 |
| 2022-03-31 | $3,732 |
| 2021-12-31 | $3,711 |
| 2021-09-30 | $3,505 |
| 2021-06-30 | $3,441 |
| 2021-03-31 | $3,374 |
| 2020-12-31 | $3,425 |
| 2020-09-30 | $3,224 |
| 2020-06-30 | $3,137 |
| 2020-03-31 | $3,102 |
| 2019-12-31 | $3,113 |
| 2019-09-30 | $2,907 |
| 2019-06-30 | $2,887 |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $45.679B | $9.455B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $211.041B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $191.072B | 99.90 |
| IQVIA Holdings (IQV) | United States | $39.790B | 21.92 |
| Edwards Lifesciences (EW) | United States | $39.062B | 24.81 |
| IDEXX Laboratories (IDXX) | United States | $35.479B | 41.78 |
| DexCom (DXCM) | United States | $27.326B | 41.15 |
| Waters (WAT) | United States | $22.831B | 33.76 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.110B | 0.00 |
| STERIS (STE) | Ireland | $21.616B | 24.91 |
| Hologic (HOLX) | United States | $18.294B | 19.30 |
| Sysmex ADR (SSMXY) | Japan | $12.864B | 40.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.499B | 12.83 |
| Globus Medical (GMED) | United States | $10.952B | 27.89 |
| Teleflex (TFX) | United States | $9.082B | 14.49 |
| Penumbra (PEN) | United States | $9.075B | 88.89 |
| Masimo (MASI) | United States | $8.696B | 42.08 |
| Glaukos (GKOS) | United States | $7.816B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.170B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.587B | 26.00 |
| Inari Medical (NARI) | United States | $3.009B | 0.00 |
| TransMedics (TMDX) | United States | $2.886B | 91.47 |
| LivaNova (LIVN) | United Kingdom | $2.804B | 16.18 |
| Veracyte (VCYT) | United States | $2.802B | 84.84 |
| Nihon Kohden (NHNKY) | Japan | $2.648B | 20.12 |
| Elekta AB (EKTAY) | Sweden | $2.286B | 18.62 |
| Tandem Diabetes Care (TNDM) | United States | $2.010B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.912B | 9.99 |
| RxSight (RXST) | United States | $1.776B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.333B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.222B | 0.00 |
| Artivion (AORT) | United States | $1.203B | 79.75 |
| OPKO Health (OPK) | United States | $1.060B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.938B | 15.95 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.741B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 38.68 |
| Mesa Laboratories (MLAB) | United States | $0.643B | 15.22 |
| SiBone (SIBN) | United States | $0.639B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.627B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.623B | 0.00 |
| Paragon 28 (FNA) | United States | $0.597B | 0.00 |
| AxoGen (AXGN) | United States | $0.555B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.501B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.360B | 19.51 |
| ClearPoint Neuro (CLPT) | United States | $0.321B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.307B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.293B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.289B | 19.43 |
| Inogen (INGN) | United States | $0.263B | 0.00 |
| NeuroPace (NPCE) | United States | $0.219B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Nevro (NVRO) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.158B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| 908 Devices (MASS) | United States | $0.124B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.111B | 16.51 |
| EDAP TMS S.A (EDAP) | France | $0.095B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.056B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.043B | 0.00 |
| Envoy Medical (COCH) | United States | $0.041B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |